The sports medicine market is expected to grow from USD 5.5 billion in 2020 to USD 7.2 billion by 2025, at a CAGR of 5.7% during the forecast period. Growth in the sports medicine market is primarily driven by factors such the increasing incidences of sports injuries, continuous influx of new products & treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.
According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID- 19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. This collaborative has also estimated that orthopedic procedures will be the most frequently canceled procedures, with 6.3 million orthopedic surgeries canceled worldwide over 12 weeks. The growth of the sports medicine market is halted due to the Covid-19 outbreak but is expected to be restored once the situation stabilises.
Globally, the incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active participation in fitness activities (as a result of the growing focus on leading healthy lifestyles).
For More Info, Get PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751
The major restraining factor for the growth of sports medicine market is high cost of implants. The cost of these implants is a major concern for market growth in countries such as India, where only a small section of the population is under insurance coverage (according to the IRDA, in 2017, 76% of the Indian population was uninsured). With an overall average cost of more than USD 12,000 in developing countries, affording such a costly treatment is still a big challenge for most of the population.
Similar to implants and prosthetics, regenerative medicine procedures are also expensive. For instance, the cost of a single PRP injection typically ranges from USD 500–2,000, whereas the cost of bone marrow stem cell injections ranges from USD 2,000–5,000 or more. Such therapeutic procedures often require more than one treatment, thus raising their overall cost.
Emerging countries such as India and China are home to a large patient base and are expected to offer potential growth opportunities for players operating in the sports medicine market primarily due to the rising disposable incomes in these countries (as a result of the rapid economic growth) and increasing participation in sports and physical activities. Also, currently, governments in these countries are undertaking initiatives to expand and modernize their respective healthcare infrastructures.
One of the major challenges for the sports medicine market is the lack of trained orthopedic professionals as orthopedic surgeons carry out most of the procedures for various sports injuries. According to a new report by the Association of American Medical Colleges (AAMC), published in April 2018, there will be a shortage of between 20,700 and 30,500 physicians for surgical specialties in the US by 2030.
In the sports medicine field, there is an increasing need for trained professionals with the relevant experience and knowledge about using orthobiologics and performing specific surgeries. Sports medicine surgeons provide diagnosis and treatment for musculoskeletal injuries and related disorders that are caused during sports activities.
Sports Medicine Market is widely used for the prevention of sports injuries as well as for the cure, recovery, and rehabilitation of athletes. The sports medicine applications market is segmented into knee injuries, shoulder injuries, foot & ankle, elbow & wrist, back & spine, hip & groin, and other injuries. The knee injuries segment held the largest share of the market in 2019, a trend that is expected to continue during the forecast period.
